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Abstract 
Schizophrenia has long been characterized solely by positive and negative symptoms of 
psychosis. It has also been typified by its widespread heterogeneity, which has impeded 
treatment outcomes. Previous attempts at reducing this heterogeneity via identifying 
symptom-based subtypes has been unhelpful and unreliable. More recently, cognitive 
deficits have been identified as prominent features of the disorder and are now included 
as necessary diagnostic criteria. The present study aimed to identify the unique 
relationships between cognitive deficits and psychotic symptoms and to establish 
subtypes based on these profiles. The findings suggest two distinct subtypes: (a) a deficit 
subtype wherein individuals display more severe psychotic symptoms and more severe 
cognitive deficits overall, and (a) a nondeficit subtype wherein individuals have less 
severe psychotic symptoms, as well as less severe cognitive deficits overall. These 
subtypes also differed on the following variables of interest: race, employment, 
education, and history of antipsychotic medication. Specifically, the Deficit subtype was 
composed of more Black participants than White, had fewer years of education, and had a 
longer duration since first prescribed antipsychotic medication. The Nondeficit subtype, 
conversely, was composed of more White participants, a longer work history, more 
education, and fewer years since first prescribed antipsychotic medication. These findings 
have potential implications for the efficacy of diagnosis, treatment, and prevention 
strategies.  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Chapter 1: Introduction 
Statement of the Problem 
 Schizophrenia is among the most severe forms of mental illness (Arieti, 1974). 
Positive and negative symptoms are prominent features of this disorder and have thus 
become central targets for treatment (Geddes, Freemantle, Harrison, & Bebbington, 
2000). Positive symptoms include auditory and visual hallucinations, delusions, 
suspiciousness, hostility, and conceptual disorganization, while negative symptoms 
include blunted affect, emotional withdrawal, apathy, stereotyped thinking, and poor 
rapport with others (Kay, Flszbein, & Opfer, 1987). More recently, cognitive deficits have 
garnered attention as viable indicators of both positive and negative symptom severity 
and have warranted further study based on their resistance to traditional treatment 
methods and high correlation with functional outcomes (Gold, 2004). Namely, severe 
cognitive deficits tend to persist despite positive and negative symptom abatement and 
therefore inhibit treatment success as a result of their hindrance on one’s ability to carry 
out activities of daily living (Gold, 2004). This finding suggests the unidirectional 
relationship between cognitive deficits and positive and negative symptoms in that 
severity of cognitive deficit is a marker of positive and negative symptom severity, 
though the same is not necessarily true in the reverse (Arieti, 1974).  
 Since its inception, schizophrenia has been thought of as a multidimensional 
construct (Carpenter, Bartko, Carpenter, & Strauss, 1976). The term schizophrenia was 
originally used to denote a group of mental illnesses that were comprised of any 
combination of positive and negative symptoms of psychosis (Carpenter et al., 1976). 
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The widespread heterogeneity inherent in schizophrenia has been observed and 
documented since antiquity, eventually inciting the use of subtypes meant to categorize 
these differences (Fenton & McGlashan, 1991). Historically, a symptom-focused 
approach to differentiating subtypes dominated clinical manuals (Fenton & McGlashan, 
1991). Some of these subtypes include paranoid, disorganized, catatonic, 
undifferentiated, and residual and were based solely on an individual’s most prominent 
symptoms (Hoenig, 1983). 
 The most recent edition of the Diagnostic and Statistical Manual of Mental 
Disorders (5th ed.; DSM–5; American Psychiatric Association, 2013) has eliminated 
these subtypes because of their lack of reliability and clinical utility. Namely, a symptom-
focused approach to diagnostic delineation is unreliable because of the transient nature of 
the symptoms and tendency for symptom overlap (Fenton & McGlashan, 1991). 
Moreover, positive and negative symptom fluctuation hinders the ability to measure and 
thus accurately diagnose subtypes within schizophrenia (Carpenter et al., 1976).  
 Despite these challenges, identifying subtypes remains an important endeavor. 
Previous researchers have successfully demonstrated that identifying phenotypic subtypes 
of heterogeneous disorders has improved diagnostic accuracy, expounded upon genetic 
etiology, and bettered treatment outcomes for autism spectrum disorder (Shao et al., 
2002), Parkinson’s disease (Dekker et al., 2003), and Alzheimer’s disease (Scott et al., 
2003). These findings suggest that this same type of refinement may be applied to 
schizophrenia to yield similar advances in conceptual, diagnostic, and treatment domains.  
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 In response to a failed symptom-focused approach to identifying effective and 
accurate subtypes, researchers and clinicians have considered the utility of cognitive 
deficits as markers of subtypes within schizophrenia instead (Fioravanti, Carlone, Vitale, 
Cinti, & Clare, 2005). Refocusing on cognitive deficits as a method of differentiation 
emerged as a result of increasing support for their correlation with distinct positive and 
negative symptoms (Elvevag & Goldberg, 2000). Furthermore, cognitive deficits are 
easily measured and observed and tend to be enduring features of schizophrenia (Hoenig, 
1983). Thus, cognitive deficits can provide information about symptom patterns and 
severity while being less susceptible to some of the limitations set forth by a symptom-
focused paradigm (Elvevag & Goldberg, 2000). 
 Although cognitive deficits are at present acknowledged as longstanding and 
central features of schizophrenia, researchers have disagreed on whether cognitive 
deficits are generalized or domain specific (Lencz et al., 2006). While some argue that 
individuals with schizophrenia have deficits across all cognitive domains, others argue 
that the deficits are specific to certain functions and based on particular symptom 
presentations (Dickinson, Ragland, Gold, & Gur, 2008). With increasing consistency, 
researchers have demonstrated that negative symptoms are correlated with frontal 
functional deficits, while positive symptoms are associated with auditory deficits and 
more widespread neural networks that underlie attention (O’Leary et al., 2000). Based on 
these emerging patterns of positive and negative symptoms, generalized deficits clearly 
do not account for the full range of symptom presentations observed in clinical practice. 
These differential impairments support the domain-specific theory of cognitive deficits in 
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schizophrenia and further suggest the existence of subtypes within schizophrenia that can 
be classified based on these cognitive deficits.  
 Neuropsychological tests have been used extensively with this population to 
further investigate the notion of generalized versus specific cognitive deficits in 
schizophrenia. Studies that support the generalized-deficit theory, however, have 
demonstrated controversial methodologies, small sample sizes, and various other 
shortcomings that belie the veracity of their results (Fioravanti et al., 2005). Researchers 
have acknowledged that a domain-specific approach to understanding neurocognitive 
deficits would lend itself more easily to profiling individuals with schizophrenia (Gray, 
McMahon, & Gold, 2013). This notion parallels the emergence of domain-specific 
cognitive deficits that are correlated with specific positive and negative symptoms (Gold, 
2004). These correlations between psychotic symptoms and specific cognitive deficits 
further implicate the existence of subtypes within schizophrenia.  
 Furthermore, studies that investigate specific versus generalized cognitive deficits 
have been ill equipped to address the question of targeted neurocognitive profiles in 
relation to symptom presentation, as they have investigated these constructs only in 
isolation (Gray, McMahon, & Gold, 2013). Distinguishing subtypes within schizophrenia 
based on differential neurocognitive profiles is essentially a novel approach to exploring 
the widespread variability of cognitive deficits observed in this disorder. Effective 
treatment is contingent upon an accurate understanding of the illness, which requires 
specification through subtypes to decrease the widespread heterogeneity of symptom 
presentations (O’Leary et al., 2000). 
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     Interventions, nonetheless, have aimed at only positive and negative symptom 
reduction and have had limited success with the latter (Dickinson et al., 2008). The 
treatment for schizophrenia is essentially a generalized regimen, regardless of variations 
in symptom presentation, and is often ineffective for individuals who deviate from the 
typical symptom profile (Arieti, 1974). The reason for this generalized treatment 
approach is trifold: (a) Clinicians lack a clear understanding of the nature of 
neurocognitive deficits and their correlation with symptom presentations, (b) positive 
symptoms have been erroneously correlated with functional outcomes and therefore 
given precedence over other features of the illness, and (c) subtypes of schizophrenia 
based on neurocognitive profiles and associated symptom presentations have yet to be 
identified (Gold, 2004). As such, identifying subtypes of schizophrenia using a domain-
specific neurocognitive approach may help to target and improve treatment, with 
particular emphasis on fostering clinical, genetic, and pharmacological studies (Velligan, 
Bow-Thomas, Mahurin, Miller, & Halgunseth, 2000). Moreover, accuracy in diagnostic 
delineation has the potential to improve not only treatment strategies and functional 
outcomes, but also prevention and research (Velligan et al., 2000).  
Purpose of the Study  
 The purpose of the present study was to stimulate the delineation of subtypes of 
schizophrenia through identifying patterns of cognitive deficits as they relate to patterns 
of symptoms in schizophrenia. Identifying these patterns of cognitive deficits and related 
symptoms  was achieved through an examination of domain-specific cognitive deficits 
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and their correlations with positive and negative symptoms among individuals suffering 
from schizophrenia.  
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Chapter 2: Review of the Literature 
Background and Overview  
 Schizophrenia, as it is now conceptualized, is a relatively new diagnostic entity. 
The term itself is fewer than 100 years old and was coined by Swiss psychiatrist Paul 
Eugene Bleuler in 1910 (Ciompi, 1980). The word is derived from the Greek words 
schizo, meaning split, and phren, meaning mind (Johnstone et al., 1978). Thus, 
historically, schizophrenia was characterized predominantly by the division or loosening 
of cognitions that are apparent in the disorder. Despite variations in name, the incidence 
of schizophrenia has been well documented since antiquity. Dementia Praecox, which 
means dementia of early life, was the original term used to classify the disorder (Bleuler, 
1950). Dementia Praecox was conceived by German psychiatrist Emil Kraepelin and was 
based on the overt cognitive deficits that characterized his patients (Johnstone et al., 
1978).  
 More generally, the term psychosis was used to typify individuals who would 
meet present-day criteria for schizophrenia. Psychosis was originally an abbreviation for 
psychic neurosis, which essentially referred to a symptom of brain disease (Aderibigbe, 
Theodoridis, & Vieweg, 1999). Brain disease was the hypothesized cause of 
schizophrenia-like symptoms, with particular emphasis given to cognitive decline and 
general impairments in cognitive processes, such as memory, speech, ideations, and 
problem solving (Bleuler, 1950). Despite an overt historical emphasis on cognitive 
deficits as its hallmark, the focal point of schizophrenia shifted once clinicians looked to 
treat, rather than to define, the disorder.  
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At present, the term psychosis is a prominent feature of schizophrenia and is 
primarily compossed of positive and negative symptoms (Aderibigbe et al., 1999). 
Positive symptoms refer to delusions, hallucinations, and thought disorganization, 
whereas negative symptoms refer to blunted affect and avolition (Liddle, 1987). Only 
more recently have cognitive deficits attained recognition as mainstays of schizophrenia 
and psychosis in general, despite being historically regarded as the apex of the disorder 
(Lewis & Lieberman, 2000). This re-focus on cognitive deficits is likely owing to the 
covert nature of cognitive deficits, rather than to the more overt portrayal of positive and 
negative symptoms in schizophrenia (Gold & Harvey, 1993). Cognitive deficits in 
schizophrenia refer to problems with attention, memory, verbal fluency, verbal learning, 
and executive functioning (Gold, 2004; Gold & Harvey, 1993; Mohamed, Paulsen, 
O’Leary, Arndt, & Andreasen, 1999). 
 Currently, the DSM–5 requires two or more of the following symptoms to warrant 
a diagnosis of schizophrenia: delusions, hallucinations, disorganized speech, grossly 
disorganized or catatonic behavior, and negative symptoms (American Psychiatric 
Association, 2013). The presence or absence of symptoms presented by any given patient 
varies considerably. Following the onset of psychosis, patients may exhibit 
predominantly negative symptoms, predominantly positive symptoms, or both (Carpenter 
Jr., & Kirkpatrick, 1988). Thus, the potential for widespread variability among 
individuals diagnosed with schizophrenia is evidenced by the magnitude of potential 
symptom combinations (Carpenter Jr., & Kirkpatrick, 1988).  
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 Owing to this variability, schizophrenia has been deemed pathophysiologically 
heterogeneous, thus posing several obstacles to the conceptualization, course, and 
treatment of the disorder (Arango, Kirkpatrick, & Buchanan, 2000). A number of studies 
have employed factor analyses to reduce heterogeneity via the establishment of 
homogenous subtypes. Despite minor differences, these studies have fairly consistently 
demonstrated the emergence of at least three subtypes of schizophrenia: hallucinations 
and delusions, disorganization of thought and behavior, and negative symptoms, all of 
which were included in subsequent editions of diagnostic manuals (Arango et al., 2000; 
Brazo et al., 2002; Gilbert et al., 2014).  
 Previous editions of the DSM, for example, have included these three subtypes. 
The most recent edition, however, has eliminated them based on symptom fluidity and 
poor clinical utility (Keefe & Fenton, 2007). Namely, these subtypes have been based on 
the symptoms of schizophrenia, which are transient and thus unreliable indicators of 
group membership (Addington, Addington, & Maticka-Tyndale, 1991; Gilbert et al., 
2014). Researchers have instead looked to cognitive deficits to understand the 
pathophysiology of positive and negative symptoms through an examination of the 
relationship of positive and negative symptoms to particular cognitive domains (Strauss, 
1993). In contrast to positive and negative symptoms, cognitive deficits are stable 
features of schizophrenia and more likely to produce consistent and reliable information 
upon further investigation (Che et al., 2012).  
 Identifying subtypes through phenotypic refinement has been successfully applied 
in other psychiatric disorders. For example, researchers studying autism spectrum 
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disorder (ASD) employed a factor analysis to identify homogenous subtypes based on 
repetitive, stereotyped behaviors that are common in ASD (Shao et al., 2002). The results 
of the analysis narrowed the chromosomal focus for the complex traits of the disorder. As 
a result, the authors suggested that phenotypic subtypes can allow for mapping of disease 
susceptibility genes, or risk factors, that can therefore have implications for prevention as 
well (Shao et al., 2002).  
 Other studies have had similar success with complex disorders, such as 
Parkinson’s disease and Alzheimer’s disease. Parkinson’s disease varies in presentation 
and onset (Dekker et al., 2003). A study that aimed to identify homogenous subtypes of 
the disorder found etiological differences between groups, which have had immediate 
implications on genetic counseling, treatment approaches, and risk prediction (Dekker et 
al., 2003). Alzheimer’s disease is an equally complex and heterogeneous disorder. The 
use of subtypes in Alzheimer’s disease has yielded homogenous groups based on age at 
onset (Scott et al., 2003) Specifically, three groups were identified: early onset, late onset, 
and very late onset (Scott et al., 2003) Genetic differences among groups have verified 
these subtypes, and they have allowed for a more thorough etiological understanding of 
the disease. Moreover, identifying these subtypes has expanded the conceptualization of 
Alzheimer’s disease beyond familial forms of the disease to include the sporadic forms of 
it as well, meaning that identifying subtypes of a heterogeneous disease has advanced the 
understanding of its pathophysiology, as well as increased diagnostic acuity (Scott et al., 
2003).  
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 Although recent advances have expounded the pathophysiology of schizophrenia, 
the extreme variability in cognitive and clinical symptoms hinders a more thorough 
understanding of the disorder, as well as impedes accurate diagnosis and efficient 
treatment options. Thus, as has been successfully demonstrated with other disorders, 
identifying subtypes based on homogenous groups within schizophrenia may likely 
benefit each of these aims.  
Cognitive Deficits 
 There is little doubt regarding the existence of cognitive deficits in schizophrenia. 
Cognitive deficits are well-replicated, stable identifiers of the disorder (Gold, 2004). Two 
theories compete, however, on the nature of cognitive deficits in schizophrenia. The first 
theory postulates that cognitive deficits in schizophrenia are broad, generalized, and 
undifferentiated (Dickinson & Harvey, 2009). The second theory states that cognitive 
deficits in schizophrenia are domain specific and focal to particular symptoms of the 
disorder (Schatz, 1998). Each of these theories has garnered a substantial amount of 
attention in schizophrenia research in recent years. The generalized-deficit theory is not 
amenable to identifying subtypes through differential neurocognitive profiles because its 
main principle states that cognitive deficits in schizophrenia are broad and homologous. 
Thus, to support the use of cognitive deficits as markers of subtypes in schizophrenia, the 
general-deficit theory must be examined and deemed unfounded.  
General Cognitive Deficits  
Cognitive deficits in schizophrenia typically predate disease onset and remain 
stable over time (Fioravanti et al., 2005). A body of literature supports a generalized-
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deficit approach to understanding cognition in schizophrenia. The generalized-deficit 
approach refers to studies that have identified a commonality across all cognitive 
domains, referred to as “g” (Dickinson et al., 2008). Specifically, researchers have 
demonstrated that cognitive deficits in schizophrenia are mediated by a common ability 
factor, which is illustrated by widespread deficits in neuropsychological performance 
across all cognitive domains (Mohammed et al., 1999). Researchers further postulate that 
this mediation is a result of high correlations between schizophrenia-related cognitive 
deficits (Gold & Harvey, 1993). A sample of studies have attempted to support the notion 
of undifferentiated cognitive impairment through analyzing neuropsychological profiles 
of individuals with schizophrenia. One of these studies has implicated as much as 63% of 
all diagnosis-related variance in cognitive performance as being accounted for by this 
general ability factor alone (Dickinson et al., 2008).  
 Similarly, studies that have compared individuals with schizophrenia to healthy 
subjects have determined that those with schizophrenia display significant cognitive 
impairments across all cognitive domains, thus supporting the generalized-deficit theory 
(Dickinson, Iannone, Wilk, & Gold., 2004; Dickinson et al., 2008; Mohammed et al., 
1999). Nonetheless, these very studies have simultaneously illustrated some domain-
specific variance for verbal memory and processing speed, indicating that at least two 
domains are specific to schizophrenia and differentiated from a general ability factor 
(Cohen, Forbes, Mann, & Blanchard, 2006; Elvevag et al., 2000). These findings, among 
others, led to the scrutiny of research that supported the generalized-deficit theory. 
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 In response, lead researchers in favor of the generalized-deficit theory worked to 
minimize methodological flaws. For example, in an attempt to avoid potential confounds 
inherent in medication effects, researchers began studying first-episode patients to amass 
support for the generalized-deficit theory (Heydebrand et al., 2004). These studies have 
also demonstrated diffuse cognitive deficits across all domains (Fioravanti et al., 2005). 
Despite seemingly generalized impairments, however, more pronounced impairments 
were evident in the results as well, specifically in verbal learning, memory, attention, and 
processing speed (Gold, 2004). More recently, a study concluded similar findings in that 
individuals with schizophrenia demonstrated generalized deficits across all functions, 
with the exception of motor skills and verbal memory (Franck et al., 2001). Thus, across 
all studies in support of the generalized-deficit theory, differential impairments in verbal 
memory are a consistent exception (Fioravanti et al., 2005; Franck et al., 2001; Gold, 
2004; Mohammed  et al., 1999).  
 In addition to the emergence of domain-specific deficits in the literature, studies 
that attempt to support the generalized-deficit theory have further methodological 
limitations, including small sample sizes, insufficient within-group experimentation, and 
poor reliability (Gold, 2004). Moreover, the vast majority of these studies likely reflect a 
sampling bias, as they have examined almost exclusively chronically ill patients (Bryson, 
Bell, & Lysaker, 1997). In doing so, these studies have not accounted for potential 
confounds that are attributable to institutionalization or long-term medication effects that 
can worsen cognitive deficits (; Bryson et al., 1997; Gold, 2004). The broad variability in 
kind and magnitude of impairment necessitates a more thorough understanding of 
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cognitive deficits in schizophrenia via a domain-focused approach. Identifying 
independent dimensions of cognitive deficits would thus allow for the development and 
implementation of effective interventions for differential impairments (Gold, 2004).  
 Overall, relevant literature suggests that the type and severity of cognitive deficits 
vary widely by patient, in much the same way that particular positive and negative 
symptoms vary by patient (O’Leary et al., 2000). Individuals with schizophrenia perform 
worse than healthy subjects on neuropsychological assessments across all domains, 
despite having within-group domain specificity (Gold & Harvey, 1993). Both within-
group analyses and analyses that compare individuals with schizophrenia to healthy 
controls often fail to detect domain-specific deficits as a result of this widespread 
variation. Conversely, studies that have compared the deficit subtype of schizophrenia 
(i.e., those high on negative symptoms and low on positive symptoms) to the nondeficit 
subtype have been able to identify domain-specific deficits, such as differential 
impairments in cognitive flexibility, by analyzing more homogenous groups (Rethelyi, 
Benkovits, & Bitter, 2012). Consequently, domain-specific deficits likely are masked by 
the clinical heterogeneity of schizophrenia, but are nonetheless present. Moreover, the 
presence of domain-specific deficits increases the plausibility of utilizing differential 
neurocognitive profiles to identify subtypes of schizophrenia.  
Domain-Specific Cognitive Deficits 
The existence of differential domains in cognition is undisputed, and the reliable 
measurement of these domains via neuropsychological assessments is equally 
uncontested (Nuechterlein et al., 2008). Moreover, neuropsychological assessments were 
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developed to capture and measure different cognitive processes, such as memory, 
attention, and problem solving (Hartlage & DeFilippis, 1983). Namely, 
neuropsychological assessments are already categorized into various domains that 
purport to measure distinct neurological substrates. The domain-specific theory, then, 
suggests differential impairment among these cognitive domains, in opposition to the 
generalized-deficit theory, which acknowledges these domains but suggests they are 
equally impaired (Gold, 2004).  
 The majority of the literature suggests that attention, working memory, processing 
speed, verbal learning, and executive functioning are characteristically impaired in 
schizophrenia (Strauss, 1993). In a recent study, authors explored whether cluster analysis 
of these cognitive domains would define separate subtypes of schizophrenia (Gilbert et 
al., 2014). The analysis yielded three clusters: one who performed in the near-normal 
range of cognitive functioning; one with severe, general impairments across all cognitive 
domains; and one with severe, selected cognitive impairments in the visual episodic 
memory and processing-speed domains (Gilbert et al., 2014). A major limitation of this 
study that likely accounts for the supposition of a generally impaired subtype rests in its 
inclusion of only four cognitive domains, with three of them related to memory. These 
domains include verbal memory, visual memory, working memory, and processing speed 
(Gilbert et al., 2014). Thus, a more inclusive analysis likely would have identified 
domain-specific deficits for this subtype as well. One also should note that the two 
severely impaired clusters were nearly indistinguishable across measures of psychiatric 
symptom severity (i.e., positive and negative symptoms of psychosis) at disease onset 
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(Gilbert et al., 2014). This finding is consistent with the general literature that suggests 
psychiatric symptoms alone are insufficient for distinguishing subtypes of schizophrenia.  
 Furthermore, this study identified relationships between clusters of cognitive 
deficits and related functional outcomes (Gilbert et al., 2014). Functional outcomes are 
defined in the literature as an individual’s ability to carry out activities of daily living, 
including independent living (Bowie et al., 2008), social functioning (Addington & 
Addington, 1999; Addington & Addington, 2000), and employment (Midin et al., 2011; 
Sanchez et al., 2009). This study used the lifetime best estimate of response to treatment 
(BER) assessment to measure functional outcomes. The BER provides a consensual 
clinical judgement based on medical records, positive and negative syndrome scale 
(PANSS) data, and a global assessment of functioning (GAF) score (Gilbert et al., 2014. 
Individuals in the generalized-cognitive-deficit cluster were more likely to have treatment 
refractory schizophrenia, whereas individuals with domain-specific cognitive deficits 
demonstrated greater improvements on the BER (Gilbert et al., 2013). Overall, the 
findings suggest that neurocognitive deficits are more central to functional outcomes than 
are psychiatric symptoms of schizophrenia. These findings indicate that cognitive deficits 
are imperative treatment targets in schizophrenia and could be better utilized in 
intervention planning through the identification of subtypes. 
 To identify specific functional outcomes as they relate to specific cognitive 
domains, a meta-analysis including 37 studies demonstrated moderate to strong effect 
sizes on functional improvements, such as engaging in community and daily activities, 
improvements in social problem solving, and psychosocial skill acquisition, for 
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individuals in the executive-functioning, memory, and attention domains of cognition 
(Green et al., 2000). This meta-analysis included studies that assessed generalized 
impairment by calculating the global/composite measures of neurocognition. The results 
demonstrated that between 20 and 60% of the variance in functional outcomes can be 
explained by neurocognition (Green, Kern, Braff, & Mintz, 2000). Studies that used a 
generalized-deficit approach, however, lacked the specificity required to determine which 
domains should be targeted for interventions (Velligan, 2000). Thus, neurocognition in 
schizophrenia is a crucial component to treatment success and requires a domain-specific 
approach for generating effective interventions (Bowie et al., 2008) Despite some 
variability, four cognitive domains are most commonly implicated in the literature as 
being differentially impaired in schizophrenia: attention, memory, processing speed, and 
executive functioning (Fioravanti et al., 2005). Given these deficits are unique to 
schizophrenia, they may elucidate potential subtypes within this diagnostic category. 
Deficits in attention, specifically, are considered to be the most fundamental in 
individuals with schizophrenia and should be the first deficit cluster to examine (Carter et 
al., 2010). 
 Attention. Attention, also referred to as vigilance, refers to one’s readiness to 
differentially respond to a target stimulus and inhibit one’s response to a nontarget 
(Saykin et al., 1991). Attentional deficits in schizophrenia are common and are often 
universally apparent, despite variations in psychiatric symptom presentations (Mass, 
Schoemig, Hitschfeld, Wall, & Haasen, 2000). Several studies have noted that deficits in 
attention, like most cognitive deficits in schizophrenia, are detectable before the onset of 
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the illness (Egeland et al., 2003). Attentional deficits in particular appear to predominate 
in studies of early schizophrenia, with some researchers illustrating childhood attentional 
deficits as a predictor for later development of the disorder (Saykin et al., 1994). In an 
early review of attentional deficits in schizophrenia, 40 studies related to attentional 
deficits in schizophrenia were examined (Cornblatt & Keilp, 1994). The results from this 
meta-analysis indicated that attention is uniquely impaired in individuals with 
schizophrenia, as compared to both healthy controls and individuals with major affective 
disorders, and were predictive of later pathophysiology (Cornblatt & Keilp, 1994).  
 To further investigate this notion, efforts shifted toward identifying specific 
attentional-deficit profiles in schizophrenia as compared to other psychiatric illnesses. In 
a study that compared subjects with schizophrenia to subjects with major depression and 
normal controls, subjects with schizophrenia demonstrated greater impairments in 
attention and speed of processing than both healthy controls and subjects with depression 
(Egeland et al., 2003). Although subjects with depression demonstrated similar 
attentional deficits, these deficits were determined to be the result of lack of effort, rather 
than caused by a manifestation of subcortical dysfunction (Egeland et al., 2003). In 
addition to attention and speed of processing, subjects with schizophrenia also 
demonstrated deficits in selective attention, which is indicative of an underlying 
impairment in executive functioning (Nuechterlein et al., 2004).  
 One should note that the vast majority of studies that investigate attentional 
deficits in schizophrenia simultaneously highlight deficits in memory, processing speed, 
and even executive functioning. The reason is trifold: (a) cognitive deficits are not 
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mutually exclusive constructs, despite neuropsychological assessments that attempt to 
categorize them (Nuechterlein et al., 2004); (b) cognitive deficits are hierarchical in 
nature, often having one (i.e., attention) as a prerequisite for another (i.e., memory; 
Egeland et al., 2003); and (c) attempts to isolate cognitive deficits in research may limit 
potential findings (Mass et al., 2000). Despite moderate correlations among cognitive 
deficits, particularly those related to attention, multicollinearity is insufficient to suggest 
true linear dependence (Shamsi et al., 2011). This notion does not necessarily support the 
generalized-deficit approach, however. Rather, it is indicative of complex relationships 
between and among cognitive deficits and clinical symptoms in schizophrenia that give 
rise to the need for equally complex and nuanced subtypes meant to categorize them. 
 In fact, several studies have illustrated within-group differences with reference to 
attentional deficits in schizophrenia (Braff, 1993; Carter et al., 2010; Lencz et al., 2006; 
McGhie & Chapman, 1961; Nieuwenstein et al., 2001). One such study found statistically 
significant differences between individuals with predominantly positive, as compared to 
predominantly negative, symptoms (Nieuwenstein, Aleman, & de Haan, 2001). 
Individuals who scored higher on measures of positive symptoms displayed poorer 
performances on tests of attention and vigilance, such as the Continuous Pairs Test 
(CPT), as compared to those with greater negative symptoms (Nieuwenstein et al., 2001). 
Conversely, a similar study found differential impairments in attention for those with 
greater negative symptoms as compared to positive symptoms (Liddle, 1987). Despite 
these differences (i.e., greater negative symptoms vs. greater positive symptoms being 
related to deficits in attention), consistent findings have confirmed the existence of 
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differential impairments in attention as they relate to symptom dimensions, suggesting 
domain specificity of within-group attentional deficits (Baxter & Liddle, 1998; Grube, 
Bilder, & Goldman, 1998; Strauss, 1993).  
 Memory. Memory is related to attention and is defined in several ways within the 
literature. Verbal memory, visual-episodic memory, short-term memory, and working 
memory are all terms used to denote this cognitive domain in the schizophrenia literature. 
Verbal memory and working memory, however, have been most consistently examined 
and demonstrate differential impairments in schizophrenia as compared to both healthy 
controls and individuals with other psychiatric illnesses (Lee & Park, 2005). Verbal 
memory refers to an individual’s ability to recall without delay as many words as possible 
from a list verbalized by an examiner, whereas working memory refers to one’s ability to 
hold and manipulate information that is held in awareness (Heinrichs & Vaz, 2004). 
Verbal memory is often assessed using the Hopkins Verbal Learning Test (HVLT), and 
working memory is most often assessed using the Letter-Number Sequencing Test (LNS; 
Keefe et al., 2003).  
 A meta-analysis that included 70 studies revealed a large effect size for both 
verbal-memory and working-memory deficits in schizophrenia (Aleman, Hijman, de 
Haan, & Kahn, 1999). These deficits were stable and widespread, despite differences in 
moderating factors, such as illness duration (Aleman et al., 1999). Furthermore, findings 
regarding memory deficits in schizophrenia are largely consistent across studies, despite 
variations in assessment tools (Lee & Park, 2005). This variation demonstrates that 
memory impairments in schizophrenia are significant enough to be detected across 
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multiple measures and are thus modality independent (Park & Holzman, 1992). Similar 
studies have demonstrated homogeneous findings, with large effect sizes for memory 
impairments in schizophrenia (Achim & Lepage, 2005).  
 In addition to between-group differences, several studies have outlined memory-
related deficits that are specific to individuals with predominantly negative symptoms 
(Addington et al., 1991; Carter et al., 1996; Cuesta & Peralta, 1995; Milev, Ho, Arndt, & 
Andreasen, 2005). One study in particular investigated the domain specificity of spatial-
working-memory deficits in schizophrenia for nonmedicated subjects (Carter et al., 
1996). The results indicated that those with higher scores on negative-symptom 
inventories produced lower scores on spatial-working-memory tasks, indicating that this 
cognitive domain is differentially impaired in individuals with fewer positive symptoms 
and greater negative symptoms (Carter et al., 1996). Additionally, these results suggest 
that these differences stem from an organic, neuropathological origin rather than from 
medication effects (Carter et al., 1996). Similar studies have had parallel findings 
indicating a strong association between greater negative symptoms and poorer memory, 
thus lending support to the domain-specific deficit theory (Addington et al., 1991; Cuesta 
& Peralta, 1995; Milev et al., 2005).  
 Processing speed. Processing speed is positively correlated with memory and is 
defined by one’s ability to quickly and correctly scan and process information. It is 
typically assessed using timed digit-symbol coding tasks (Schatz, 1998). In Dickinson, 
Ramsey, and Gold’s seminal meta-analytic study (2007), processing speed was identified 
as the single largest cognitive deficit in schizophrenia (Dickinson et al., 2007). Compared 
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to healthy controls, individuals with schizophrenia demonstrated significant impairment 
in processing speed (Dickinson et al., 2007). The second largest effect size among the 
cognitive domains was in executive-functioning tasks, such as category fluency, wherein 
subjects are given 1 minute to generate as many unique words within a category as they 
can (Dickinson et al., 2007). More recently, Knowles, David, and Reichenberg (2010) 
replicated these findings after adding 11 studies to the original analysis. Their results 
yielded an almost identical effect size of d = -1.50, indicating that processing speed is 
consistently and significantly deficient in individuals with schizophrenia and is therefore 
considered a hallmark of the disorder’s neurocognitive profile (Knowles et al., 2010). 
 In addition to studies that compared processing speed to other cognitive domains 
in schizophrenia, researchers also examined longitudinal changes in relation to 
processing-speed tasks. In a study that compared 95 hospitalized patients with 
schizophrenia to 53 healthy age-matched controls, processing speed was found to be the 
single best predictor of longitudinal outcomes of autonomy, self-care, vocational 
functioning, and social functioning for individuals with schizophrenia (Sanchez et al., 
2009). Furthermore, studies suggest that processing speed mediates the relationship 
between deficits in executive-functioning and functional outcomes and that processing 
speed mediates a broader diversity of cognitive deficits overall (Ojeda et al, 2008). 
Specifically, the severity of processing-speed deficits was predictive of the severity of 
executive-functioning deficits (Ojeda, Pena, Sanchez, Elizagarate, & Ezcurra, 2008). 
 Additionally, within-schizophrenia differences were found among individuals 
with greater negative symptoms. Similar to individuals with differential memory deficits, 
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individuals who scored higher on measures of negative symptoms than positive 
symptoms exhibited greater processing-speed deficits (Milev et al., 2005). An early study 
examined the relationship between prognosis and processing speed. Prognosis was 
defined by functional outcomes and severity ratings on clinical and cognitive symptoms 
(Saccuzzo & Braff, 1981). The findings from this study illustrated differential 
impairments within schizophrenia through identifying those with a poorer prognosis, 
meaning those likely to have more severe clinical and cognitive symptoms as well as 
poorer functional outcomes, as having slower processing speed (Saccuzzo & Braff, 
1981). Those with a better prognosis, meaning those more likely to have better functional 
outcomes and less severe cognitive and clinical symptoms as the disorder progressed, had 
faster processing speed that could even be reversed with remediation and practice 
(Saccuzzo & Braff, 1981). This finding indicates domain specificity for processing-speed 
deficits within schizophrenia based on other disorder-related factors.  
 Executive functioning. Executive functioning is defined by tasks that require 
complex thought and problem-solving abilities to carry out goal-directed thoughts and 
behaviors (Kerns, Nuechterlein, Braver, & Barch, 2008). Executive functioning is 
thought to engage several regions of the brain and has been consistently noted as a 
cognitive-deficit domain in schizophrenia (Johnson-Selfridge & Zalewski, 2001. Much 
like deficits in attention, deficits in executive functioning are present during the 
prodromal phase of the disorder and have been found in adolescents at risk for 
developing schizophrenia (Fossati, Amar, Raoux, Ergis, & Allilaire, 1999). Furthermore, 
executive-functioning deficits in schizophrenia are often typified by psychosocial 
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impairments and are more highly correlated with functional outcomes than any other 
cognitive domain (Orellana & Slachevsky, 2013).  
 Executive functioning is measured by a variety of assessments, including the 
Wisconsin Card Sorting Test (WCST), Trail Making B (TMB), and verbal/design fluency 
tests (Minzenberg, Laird, Thelen, Carter, & Glahn, 2009). A meta-analysis that included 
71 studies revealed that individuals with schizophrenia were impaired in executive 
functioning relative to healthy controls (Johnson-Selfridge & Zalewski, 2001). Similarly, 
individuals with schizophrenia performed 0.40 standard deviations below individuals 
with other psychiatric illnesses on executive-functioning tasks (Johnson-Selfridge & 
Zalewski, 2001).  
 Although deficits in executive functioning have been linked to a variety of 
psychiatric illnesses, neuroimaging studies have illustrated that executive functioning is 
differentially impaired in individuals with schizophrenia and that relationships between 
executive functioning and psychiatric symptoms were evident (Elliott, 2003).  Findings 
from several studies indicate that executive-functioning deficits are differentially related 
to negative symptoms rather than to positive symptoms in a way that suggests that 
abstract reasoning and problem-solving abilities may be intact in individuals who are 
high on positive symptoms and low on negative symptoms (Nieuwenstein & Aleman, 
2001). A similar study also found that executive functioning was differentially impaired 
for individuals with a greater number of hospitalizations and a varying degree of severity 
of executive-functioning-deficit based on positive and negative symptom severity. These 
IDENTIFYING SUBTYPES OF SCHIZOPHRENIA                                                       25
findings lend credence to the notion that positive symptoms are pathologically distinct 
from other facets of the disorder (Nieuwenstein, Aleman, & de Haan, 2001).  
Positive Symptoms  
 Positive symptoms have been the most widely studied feature of schizophrenia in 
part because of their overt nature and amenability to assessment tools (Grube et al., 
1998). As a result, positive symptoms, particularly auditory hallucinations, have been 
given precedence over other facets of the disorder (Millan, 2000). An earlier, 
parsimonious model of schizophrenia attempted to dichotomize psychiatric symptoms 
through introducing the positive-negative paradigm (Peralta, De Leon, & Cuesta, 1992). 
This dichotomy was said to emerge as a result of the natural clustering of individuals into 
either a positive-dominant or negative-dominant group (Liddle, 1987).  
 Most often in the literature, however, three symptom groups would emerge: (a) 
individuals who scored high on assessments of positive symptoms, but low on 
assessments of negative symptoms; (b) individuals who scored high on assessments of 
negative symptoms, but low on positive symptoms; and (c) individuals who had roughly 
equal scores on assessments of both positive and negative symptoms (Marneros & 
Andreasen, 1992). Despite the inclusion of other variables and symptoms over time, the 
positive-negative symptom paradigm continues to prevail in diagnostic manuals and 
subsequent treatment strategies for schizophrenia.  
 Positive symptoms in schizophrenia include hallucinations, delusions, and 
disorganized speech. More than 50% of all cases of schizophrenia have been reported to 
include at least one positive symptom (David & Appleby, 1992). One of the largest 
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criticisms of focusing solely on positive symptoms in schizophrenia is that they have 
little clinical utility for predicting functional outcomes, whereas the same cannot be said 
of other features of the disorder, such as negative symptoms and cognitive deficits 
(Möller et al., 2000). Nonetheless, researchers continued to posit the high frequency, 
good discriminability, and diagnostic utility of positive symptoms in schizophrenia 
(Zimmerman, Favrod, Trieu, & Pomini,  2005).  
 While positive symptoms may be the most characteristic feature of schizophrenia, 
their utility is limited to detecting the presence of the disorder (David & Appleby, 1992). 
Positive symptoms alone are not practical markers for identifying schizophrenia 
subtypes. Furthermore, positive symptoms respond better to psychopharmacological 
interventions than any other feature of the disorder, and often require self-report as the 
primary means to detect them (Andreasen & Flaum, 1991). Given that the majority of 
individuals with schizophrenia are treated psychopharmacologically, positive symptoms 
will be too transient to detect nuanced subtypes (McGlashan & Fenton, 1991). 
Specifically, this method of identifying subtypes has been deemed phenomenologically 
unstable and temporally unsound (McGlashan & Fenton, 1991). Positive symptoms are 
only one facet of this complex disorder. Thus, identifying accurate and reliable subtypes 
necessitates a comprehensive examination of the disorder in its entirety, including 
positive symptoms, negative symptoms, and cognitive deficits.  
Negative Symptoms 
 Negative symptoms of schizophrenia were originally conceptualized as secondary 
features of the disorder (Andreasen, 1982). Negative symptoms include apathy, flattened 
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affect, social withdrawal, and avolition (Erhart, Marder, & Carpenter, 2006). The 
possibility that negative symptoms could be present in the absence of positive symptoms 
soon became apparent, piquing clinical interest thereafter (Andreasen & Flaum, 1991). 
Unlike positive symptoms, negative symptoms remain largely unaffected by 
antipsychotic medications (Erhart et al., 2006). Their resistance to traditional treatment 
methods, coupled with a growing emphasis on predicting functional outcomes, placed 
negative symptoms at the forefront of schizophrenia research (Andreasen & Flaum, 
1991). 
 Attempts to subtype schizophrenia through the examination of negative symptoms 
soon emerged. Researchers believed that patients with predominant negative symptoms 
belonged to a differentiated “deficit” subtype (Muesser, Douglas, Bellack, & Morrison, 
1991). Longitudinal studies attempted to examine the influence of negative symptoms on 
functional outcomes. The findings from these studies suggested that individuals with 
many negative symptoms had poorer premorbid functioning, partial to no remissions 
during the initial phase of the illness, and an overall progressive pathophysiology leading 
to permanent disability (Fenton & McGlashan, 1991). Individuals with fewer negative 
symptoms, however, demonstrated a better prognosis, acute onset, and more frequent 
partial remissions (Fenton & McGlashan, 1991).  
 Despite some predictive utility, however, negative symptoms were neither 
common enough nor specific enough to schizophrenia on their own to be useful in 
identifying subtypes (Andreasen & Flaum, 1991). Studies that have examined the 
reliability of using symptoms as markers of subtypes alone have demonstrated their lack 
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of accuracy, soundness, and clinical utility (McGlashan & Fenton, 1991; Spitzer, 
Endicott, & Robins, 1978), suggesting that a reductionistic model for identifying 
subtypes of schizophrenia is unfeasible. Instead, the complexities inherent in the disorder 
must be accounted for to produce a viable model for subtypes. This accountability 
includes a holistic examination of psychiatric symptoms, both positive and negative, and 
their relationships with cognitive deficits. Only a comprehensive review of the disorder 
and its facets can yield a practical and valid basis for schizophrenia subtypes. 
 Relationship Between Psychiatric Symptoms and Cognitive Deficits   
 Once cognitive deficits were acknowledged as primary characteristics of 
schizophrenia, researchers evaluated the relationship between cognitive deficits and 
positive and negative symptoms (Strauss, 1993).  In general, failures of information 
processing and self-monitoring through interactions of frontal and septohippocampal 
brain pathways are thought to be implicated in positive symptoms, whereas negative 
symptoms relate to abnormal interactions between the frontal and striatal systems 
(Strauss, 1993).  
 More specifically, positive symptoms are correlated with auditory-processing 
deficits and broad neural networks that underlie attention (O’Leary et al., 2000), and 
negative symptoms have been correlated with frontal-functional deficits (Gold, 2004). In 
an attempt to further specify the nature of these relationships, studies looked to specific 
symptoms within the positive-negative dichotomy. Namely, researchers determined that 
hallucinations were correlated with information-processing deficits (i.e., an inability to 
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accurately identify the source of the information), and delusions were related to abnormal 
sensory input and faulty inference processes (Strauss, 1993).  
 Likewise, a study that compared 35 individuals with schizophrenia to 35 healthy 
age-matched controls found that the individuals with schizophrenia had cognitive-deficit 
profiles that were distinct from those of healthy controls and were specific to differential 
symptom profiles (Brazo et al., 2002). Essentially, individuals in the schizophrenia group 
who scored high on assessments of positive symptoms had some performances of 
executive functioning in the normal range, indicating some preservation of cognitive 
skills in that domain (Brazo et al., 2002). This finding is consistent with later reports that 
suggest executive functioning is differentially impaired in individuals with stronger 
negative symptoms than positive symptoms and further indicates that negative symptoms 
have a stronger association than positive symptoms to cognitive deficits (Che et al., 2012; 
Harvey, Green, Bowie, & Loebel, 2006).  
 The relationship between negative symptoms and cognitive deficits has attracted 
much interest in the past 15 years. Though whether these variables are essentially 
defining the same construct has been debated, negative symptoms have been widely 
accepted as conceptually distinct from cognitive deficits (Brazo et al., 2002). One of the 
most significant findings drawn from this literature is that negative symptoms and 
cognitive deficits are correlated in severity on a cross-sectional basis and that both are 
highly correlated with functional outcomes (Harvey et al., 2006). Although these 
constructs seem to overlap, support for models that conceptualize negative symptoms and 
cognitive deficits as two separate dimensions of schizophrenia rests in their divergent 
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neuropathology and subsequent variation in associated affected brain regions (Harvey et 
al., 2006).  
 Previous studies have reached similar conclusions regarding the correlations 
between negative-symptom severity and cognitive-deficit severity. Upon evaluating 38 
individuals with schizophrenia at two time periods, analyses revealed that higher ratings 
of negative symptoms were more likely to be associated with cognitive deficits as 
compared to higher ratings of positive symptoms (Addington et al., 1991). Likewise, a 
cross-sectional analysis found similar associations between positive symptoms and 
cognitive deficits, though positive symptoms were also correlated with cognitive deficits 
in the attention and memory domains (Savilla, Kettler, & Galletly 2008).   Most 
consistently, research has highlighted the relationship between negative symptoms and 
deficits in visuospatial-constructional skills, language, and executive functioning and the 
relationship between positive symptoms and deficits in memory and attention (Milev et 
al., 2005). Processing speed has been shown to be impaired in both positive-symptom-
dominant and negative-symptom-dominant profiles (Bowie et al., 2008). An overview of 
these associations from the most seminal studies are outlined in Table 1.  
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Table 1 
Outcomes of Studies Assessing the Relationship Between Psychotic Symptoms and 
Cognitive Deficits in Schizophrenia from 1991-2004 
Study Assessment 
measures
Symptom 
outcomes
Cognitive 
outcomes
Combined symptom 
and cognitive 
outcomes
Mahurin 
et al., 
1998
Symptom: 
BPRS 
Cognitive: 
TMT, visual 
search, 
verbal 
fluency, 
HVLT, 
WCST, 
stroop, digit 
span, digit 
symbol 
Factor loadings 
revealed 3 
distinct 
symptom 
groups with 
highest ratings: 
(a) Withdrawal 
(b) Conceptual 
disorganization
, (c) Reality 
distortion 
Deficits identified 
in processing 
speed, attention/
vigilance, and 
verbal memory
1. Withdrawal 
(negative) 
symptom group 
associated with 
deficits in verbal 
memory and 
processing speed 
2. Conceptual 
disorganization 
(positive) symptom 
group  associated 
with deficits in 
verbal memory and 
attention/vigilancea 
3. Reality distortion 
(positive) symptom 
group associated 
with deficits in 
verbal memory a 
Heydebra
nd et al., 
2004
Symptom: 
PANSS 
Cognitive: 
WMS-R, 
WCST,  
RAVLT, 
CPT-IP, 
stroop 
2 general 
symptom 
groups: 
Negative 
symptoms and 
positive 
symptoms 
Differential 
impairments 
identified in 
memory, 
attention, verbal 
fluency, 
psychomotor 
speed, and 
executive 
function 
1. Higher rates of 
negative symptoms 
were associated 
with deficits in 
memory, verbal 
fluency, 
psychomotor 
speed, and 
executive function 
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Addington 
et al., 
1991
Symptoms: 
SAPS, 
SANS 
Cognitive: 
WAIS, Rey’s 
complex 
figure, word 
fluency, 
design 
fluency, 
WCST
2 general 
symptom 
groups: 
Negative 
symptoms and 
positive 
symptoms 
Differential 
impairments 
identified in 
general 
intellectual 
functioning (IQ), 
executive 
functioning, 
verbal fluency, 
and memory 
1. High rates of 
negative symptoms 
and low rates of 
positive symptoms 
were more likely to 
be associated with 
lower general IQ 
and deficits in 
executive 
functioning  
2. Higher rates of 
positive symptoms 
were associated 
with deficits in 
verbal memory a 
Study Assessment 
measures
Symptom 
outcomes
Cognitive 
outcomes
Combined symptom 
and cognitive 
outcomes
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Berman et 
al., 1997
Symptom: 
PANSS 
Cognitive: 
WCST, 
TMT, WAIS-
R, verbal 
fluency, digit 
span, digit 
symbol, 
block design, 
visual recall/
recognition
1. 3 groups: 
positive 
symptoms, 
negative 
symptoms, 
mixed 
positive and 
negative 
symptoms  
2. Positive and 
negative 
symptoms 
showed a 
trend toward 
direct 
correlation (r 
= .30), but 
were 
associated 
with 
different 
cognitive 
deficits   
Differential 
impairments 
identified in 
executive 
functioning, 
visuospatial 
constructional 
skills, verbal 
memory, and 
attention 
1. Higher rates of 
negative symptoms 
are more likely to 
be associated with 
deficits in 
executive 
functioning and 
deficits in 
visuospatial 
constructional skilla 
2. Higher rates of 
positive symptoms 
are more likely to 
be associated with 
deficits in verbal 
memory and 
auditory attention a 
3. No associations 
were found 
between positive/
negative symptoms 
and global 
functioning (i.e., 
IQ)  
Study Assessment 
measures
Symptom 
outcomes
Cognitive 
outcomes
Combined symptom 
and cognitive 
outcomes
IDENTIFYING SUBTYPES OF SCHIZOPHRENIA                                                       34
Cuesta & 
Peralta, 
1995
Symptom: 
SAPS, 
SANS 
Cognitive: 
Luria’s test 
(executive 
functioning), 
verbal 
memory, 
visual 
memory, 
digit symbol, 
TMT, Rey’s 
complex 
figure, face-
matching 
test
3 groups 
“syndromes”: 
positive 
syndrome, 
negative 
syndrome, and 
disorganized 
syndrome 
Differential 
impairments 
identified in 
visual-motor 
performance, 
verbal memory, 
attention, and 
processing speed
1. Higher rates of 
positive symptoms 
were correlated 
with better 
performances on 
visual-motor tasks  
2. Higher rates of 
negative symptoms 
were correlated 
with worse 
performances on 
visual-motor tasks  
3. Higher rates of 
disorganized 
symptoms were 
associated with 
worse 
performances on 
visual-motor 
functioning, 
processing speed, 
and verbal memory 
Study Assessment 
measures
Symptom 
outcomes
Cognitive 
outcomes
Combined symptom 
and cognitive 
outcomes
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Note., BPRS = Brief Psychiatric Rating Scale, TMT = Trail Making Test, HVLT = 
Hopkins Verbal Learning Test, WCST = Wisconsin Card Sorting Test, PANSS = Positive 
and Negative Syndrome Scale, WMS-R = Wechsler Memory Scale-Revised, RAVLT = Rey 
Auditory Verbal Learning Test, CPT = Continuous Performance Test, CPT-IP = 
Continuous Performance Test-Identical Pairs, SAPS = Scale for the Assessment of 
Positive Symptoms, SANS = Scale for the Assessment of Negative Symptoms, WAIS = 
Wechsler Adult Intelligence Scale, WAIS-R = Wechsler Adult Intelligence Scale-Revised.  
a indicates patterns of similar findings across studies.  
Summary 
 Despite overt and reliable associations between psychiatric symptoms and 
cognitive deficits, researchers have yet to utilize these associations as a means to identify 
O’Leary 
et al., 
2000
Symptom: 
SAPS, 
SANS 
Cognitive: 
WAIS-R, 
WCST, 
TMT, CPT, 
logical 
memory, list 
learning, 
verbal 
fluency, 
stroop, Rey’s 
complex 
figure
3 groups 
“syndromes”: 
positive 
syndrome, 
negative 
syndrome, and 
disorganized 
syndrome 
Deficits identified 
in verbal fluency, 
verbal memory, 
processing speed 
1. Negative symptoms 
were correlated 
with greater 
deficits in verbal 
memory, nonverbal 
memory, verbal 
fluency, and 
processing speed 
2. Disorganized 
symptoms were 
correlated with 
greater deficits in 
executive 
functioning and 
global functioning 
(i.e., IQ) 
3. Positive symptoms 
were correlated 
with better 
performances on 
the Rey’s complex 
figure drawing test 
(visual-motor 
memory)
Study Assessment 
measures
Symptom 
outcomes
Cognitive 
outcomes
Combined symptom 
and cognitive 
outcomes
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subtypes and thereby decrease the widespread heterogeneity that has impeded treatment 
success in schizophrenia (Kraus & Keefe, 2007). Three general factors related to 
treatment success in schizophrenia have been identified in the literature: treatment-related 
factors, patient-related factors, and system-related factors, such as access to care, 
socioeconomic status, and level of education (Buckley, 2008). Specifically, utilizing 
generic treatment protocols without regard for patient-specific variables has led to limited 
treatment success (Buckley, 2008). This limited success has resulted from a lack of 
diagnostic precision; unspecific treatment aims; and the employment of singular, 
symptom-focused interventions (Kraus & Keefe, 2007). 
 Global perspectives lead to problematic, generalized treatments that hinder 
functional outcomes. Thus, the need to identify subtypes in schizophrenia is trifold: (a) to 
improve diagnostic clarity and accuracy, (b) to improve treatment outcomes, and (c) to 
better the etiological understanding of schizophrenia as a means to support risk and 
prevention strategies. Support for this tripartite reasoning rests in failed attempts at 
establishing subtypes of schizophrenia in the past through simplistic models that focused 
on only one dimension (i.e., clinical symptoms) of schizophrenia. Chiefly, these failures 
have resulted from oversimplifying the facets of the disorder through a psychiatric 
symptom-only focus (Keefe & Fenton, 2007). Owing to treatment response and 
occasional symptom overlap, positive and negative symptoms are unreliable and 
insufficiently equipped to identify subtypes of schizophrenia in isolation (Liddle, 1987). 
Instead, the identification of subtypes in schizophrenia requires an all-inclusive model 
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wherein differential profiles of neurocognition and psychiatric symptoms are taken into 
account.  
 The first step toward achieving this goal requires an examination of the 
relationships between psychiatric symptoms and cognitive deficits in schizophrenia. 
Next, a broader examination of these relationships should be applied to identify a 
clustering of homogenous groups, meaning that within these symptom-deficit 
relationships distinct subtypes will emerge.  
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 Chapter 3: Hypotheses 
1. It is hypothesized that negative symptoms of psychosis will be positively correlated 
with deficits in executive functioning and processing speed for individuals with a 
diagnosis of schizophrenia, as supported by the literature. This hypothesis is in 
accordance with previous studies in which distinct neurological substrates are 
associated with negative, as compared to positive, psychiatric symptoms in 
schizophrenia (Addington et al., 1991; Berman et al., 1997; Brazo et al., 2002; Cuesta 
& Peralta, 1995; Mahurin, Velligan, & Miller, 1998; O’Leary et al., 2000). 
2. It is further hypothesized that positive symptoms of psychosis will be positively 
correlated with attentional and memory-related cognitive deficits for individuals with a 
diagnosis of schizophrenia, as supported by numerous study findings (Addington et al., 
1991; Berman et al., 1997; Brazo et al., 2002; Cuesta & Peralta, 1995; Mahurin, 
Velligan, & Miller, 1998; O’Leary et al., 2000). 
3. It is equally hypothesized that the application of a cluster analysis will reveal clinical 
subtypes of schizophrenia through identifying differential neurocognitive and 
symptomatic profiles that reflect the aforementioned correlations.  
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Chapter 4: Methodology 
Participants  
 The present study used a secondary analysis of data collected by the NIMH-
funded Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Study, which 
was a nationwide, public-health clinical trial designed to measure the comparative 
effectiveness of first- and second-generation antipsychotic medications. The CATIE study 
took place between January 2001 and December 2004 at 57 clinical sites in the United 
States. Patients were randomized algorithmically under double-blind conditions to 
receive one of five antipsychotic medications. Eligible participants from the original 
study (N = 1,460) were aged 18 to 65 years and met Diagnostic and Statistical Manual of 
Mental Disorders (4th ed.; DSM-IV; American Psychiatric Association, 1994) criteria for 
schizophrenia as determined by the Structured Clinical Interview for DSM-IV Axis I 
disorders (SCID-I). The original clinical sites involved in recruitment included 16 
university clinics, 10 state mental-health agencies, seven Veterans Affairs Medical 
Centers, six private nonprofit agencies, four private-practice sites, and 14 mixed-system 
sites. Primary demographic and clinical characteristics are outlined in Table 2.  
 To eliminate potential confounds inherent in incorporating preexisting categorical 
differentiations among DSM-IV categories, only individuals with a primary diagnosis of 
schizophrenia were included in the current study. Individuals with a diagnosis other than, 
or secondary to, schizophrenia as indicated by the SCID-I were excluded. Furthermore, 
patients with a diagnosis of mental retardation or other cognitive disorders; patients with 
a history of only one schizophrenic episode; or those with a serious or unstable medical 
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condition were excluded. Additionally, only individuals with complete neurocognitive 
and symptomatic data were included in the current study.  
Measures  
Positive and Negative Syndrome Scale (PANSS)  
 The Positive and Negative Syndrome Scale (PANSS; Kay, Fiszbein, & Opler, 
1987) is a 30-item, rater-administered scale designed to assess three dimensions of 
psychosis: positive symptoms, negative symptoms, and general psychopathology (Kay et 
al., 1987). Each item (symptom) is accompanied by a definition and specific anchoring 
criteria to assist in scoring. Items are scored on a 7-point Likert scale ranging from 1 
(absent) to 7 (extreme). Anchoring criteria are provided for all seven rating points. Of the 
30 total items, seven items correspond to positive symptoms, another seven items 
correspond to negative symptoms, and the remaining 16 items correspond to general 
psychopathology. A total symptom severity score is yielded by averaging all 30 item 
ratings.  
 The PANSS has been used widely in clinical studies of psychosis and has 
demonstrated reliability across a variety of patient populations. The average interrater 
reliabilty for the PANSS is strong (0.82; Kay, Opler, & Lindenmayer, 1988). At present, 
the PANSS is the most frequently used assessment of psychotic symptoms, and it has 
consistently demonstrated reliable and valid psychometric properties that are over and 
above those of similar instruments, such as the Brief Psychotic Rating Scale (BPRS) 
(Faustman & Overall, 1999). 
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Continuous Performance Test, Identical Pairs Versions (CPT-IP)  
The Continuous Performance Test, Identical Pairs Versions (CPT-IP; Cornblatt, 
Risch, Faris, Friedman, & Erlenmeyer-Kimling., 1988) is an assessment that measures 
attention and vigilance. The CPT-IP has three conditions that are comprised of 150 trials 
each. The trials increase in difficulty as the task progresses. The CPT-IP requires the 
participant to identify identical pairs within a continuous presentation of stimuli. Each 
stimulus is presented on a computer screen at the rate of one stimulus per second 
(Cornblatt et al., 1988). The first condition presents two-digit numbers continuously, and 
the participant is asked to raise his or her finger each time a number presented is identical 
to the previous number presented. The second condition uses three-digit numbers, and the 
third condition uses four-digit numbers. The CPT-IP was normed on a schizophrenia and 
major-affective-disordered population and has high test-retest reliability (Cornblatt et al., 
1988). The CPT-IP is scored by the total number of correctly identified pairs, ranging 
from 0 to 30, with higher scores indicating better attentional capacity (Cornblatt et al., 
1988).  
Wechsler Adult Intelligence Test-Revised (WAIS-R) Digit Symbol Test  
The Wechsler Adult Intelligence Test-Revised (WAIS-R) Digit Symbol Test 
(Wechsler, 1955) is an assessment of processing speed in which participants are presented 
with numbers and associated symbols. The participant’s task is to copy as many symbols 
associated with numerals as possible in 90 seconds. The score is derived from the sum of 
correctly copied symbols, ranging from 0 to125, with higher scores indicating faster 
processing speed. The digit symbol subtest on the WAIS-R is considered to be one of the 
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most reliable indicators of processing speed in a psychiatric inpatient sample with a large 
reliability coefficient (.77; Boone, 1992).  
Wisconsin Card Sorting Test, 64-Card Computerized Version (WCST-64P)  
The Wisconsin Card Sorting Test, 64-Card Computerized Version (WCST-64P; 
Kongs, Thompson, Iverson, & Heaton, 2000) is a measure of executive functioning. The 
WCST-64P requires complex categorization and problem solving based on the 
examiner’s feedback. The participant is initially presented with four different cards that 
remain on the screen. The computer then presents one card at a time, and the participant’s 
task is to match the current card to one of the original four. After the participant makes 
his or her choice, the computer says either “correct” or “incorrect” without further 
instruction. The cards are appropriately matched on three rules: color, shape, and number. 
The rule changes after 10 consecutive correct responses throughout the administration, 
without the participant knowing. The WCST-64P is scored by averaging the number of 
perseverative errors and the number of categories, or rules, completed. Higher scores 
indicate better executive functioning. Scores are compared to the corresponding norms 
located in the manual to determine relative interpretations. The WCST-64P has 
demonstrated high reliability and validity in psychiatric populations (Lysaker & Bell, 
1994).  
Hopkins Verbal Learning Test (HVLT)  
The Hopkins Verbal Learning Test (HVLT; Brandt & Benedict, 1991) is an 
assessment of verbal memory. The examiner reads aloud a list of 12 words. The 
participant is then asked to recall as many words as possible. There is a total of four trials, 
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with the same set of 12 words read at the start of each trial. The HVLT is scored by the 
sum of words correctly recalled across all four trials. Higher scores indicate better verbal 
learning and verbal memory and can be compared to the norms provided in the manual to 
make interpretations relative to an age-matched sample. Scores range from 0 to 36. The 
HVLT was designed for repeated testing and demonstrates high test-retest reliability 
(Benedict, Schretlen, Groninger, & Brandt, 1998).  
Letter-Number Span Test of Auditory Working Memory  
The Letter-Number Span Test of Auditory Working Memory (Gold, Carpenter, 
Randolph, Goldberg, & Weinberger, 1997) is an assessment of working memory. 
Participants are aurally presented with sequences of letters and numbers combined (e.g., 
N6G2). Participants are then asked to reorder the sequences by stating the numbers first, 
from lowest to highest, followed by the letters in alphabetical order. The Letter-Number 
Span Test of Auditory Working Memory is scored by the sum of correct sequences. 
Scores range from 0 to 21, where higher sums indicate better working memory. This 
assessment has been widely used in the schizophrenia population and demonstrates high 
test-retest reliability (Nuechterlein et al., 2008).  
Computerized Test of Visuospatial Working Memory  
The Computerized Test of Visuospatial Working Memory (Hershey, Selke, 
Fucetola, & Newcomer, 1999) is an assessment of working memory with visual stimuli. 
The participant must focus on a central cross fixation point on a computer screen while a 
cue appears for 150 milliseconds in one of 32 possible locations around the cross. After a 
delay period of 5 or 15 seconds, the participant must identify, via pointing, where on the 
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computer screen they remember seeing the cue. There are eight trials total. The 
Computerized Test of Visuospatial Working Memory is scored by the mean error in 
millimeters of the distance between the recalled cue point and the actual cue point. 
Higher scores, or mean error rates, indicate poorer visuospatial working memory. Mean 
error rates can be compared to the normative data provided in the manual for 
interpretation. This test is considered to be a reliable and valid indicator of one’s 
visuospatial working memory (Keefe et al., 2003).  
Procedure 
 The parent study used a Neurocognitive Assessment Unit evaluator to determine 
proficiency of each tester before the initiation of the trial at its site. The performance of 
these testers were monitored throughout the study via reviews of their protocols and 
scoring sheets. Raw data collected from each site were entered into a web-based data 
entry system. To the extent possible, each participant was rated by the same examiner 
across all assessments. The timing of the assessments occurred at baseline, 2 months, 6 
months, and 18 months or end of study. For the purposes of this study, only data collected 
at the baseline neurocognitive trials were used. The purpose of using only baseline trials 
was to minimize the possibility of medication effects on cognitive performance, being 
that the original study trialed typical and atypical antipsychotic medications. By using 
baseline data only, participants would have been functioning under their usually 
prescribed, stabilized medication, which may be an atypical or typical antipsychotic. 
Being that most individuals with schizophrenia are medicated on one of these two types 
of antipsychotics, this sample should accurately represent the population, and thus have 
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good generalizability. The procedure for the present study included entering the symptom 
and neurocognitive data into a cluster analysis via SPSS. This study is the first known 
report of identifying subtypes based on differential neurocognitive profiles in relation to 
symptom patterns from this archival dataset. The dataset was obtained through NIMH via 
a Data Use Certificate (DUC) request in which the study’s aims, investigators, and 
potential implications were outlined. Upon review by the NIMH, the DUC was approved 
pending IRB approval, and access codes were provided to the primary investigators to 
access the data via a web-based system. An expedited application was placed with the 
IRB board at Philadelphia College of Osteopathic Medicine before the data were 
accessed.  
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Chapter 5: Statistical Plan 
 Descriptive analyses were performed on demographic variables, such as age, 
gender, and ethnicity.  
Hypothesis 1 
 The first goal of this study was to identify the relationship between negative 
symptoms of psychosis and distinct neurocognitive deficits. Both symptom scores and 
neurocognitive scores are continuous measures; therefore, a Pearson correlation was used 
to identify the relationship between negative symptoms and neurocognitive domains 
using SPSS.  
Hypothesis 2 
 The second goal of this study was akin to the first, that is, to identify the 
relationship between positive symptoms of psychosis and distinct neurocognitive deficits. 
The statistical analysis to examine this aim mirrored that of the first. To identify the 
relationship between positive symptoms and neurocognitive domains, a Pearson 
correlation was conducted in SPSS.  
Hypothesis 3 
 The primary aim of this study was to identify subtypes of schizophrenia through 
identifying homogenous groups that cluster together based on both symptomatic and 
neurocognitive data. To identify homogenous subtypes of patients that are independent 
from each other, four cognitive domains and two symptom domains were entered into a 
cluster analysis using SPSS. The four cognitive domains included attention, processing 
speed, executive functioning, and memory. The two symptom domains included positive 
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and negative symptom categories based on the PANSS. The simplest interpretable 
solution that fit the data was chosen, and each patient was assigned to the most congruent 
cluster. Listwise deletion was employed for participants with missing values in any 
domain.  
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Chapter 6: Results 
Descriptive Statistics 
 A total of 1,147 participants from the parent study met the inclusionary and 
exclusionary criteria for the present study. Demographics of study participants are 
outlined in Table 2. Of the participants, 74.4% were male and 25.1% were female. The 
average age of the participants was approximately 40 years old, with a range of 18 to 67 
years old. Participants averaged 11.62 total years of education, with a range of 1 to 21 
years of education, and had an average of 13.6 years since first prescribed antipsychotic 
medication.  A majority of the participants were unemployed (82.9%). The sample 
consisted of 61.6% of people who identified as Caucasian, 33.1% who identified as 
African American, and 2.4% who identified as Asian. Unknown race accounted for 0.5% 
of participants.  
Table 2 
Demographic Characteristics of CATIE Participants with Neurocognitive Data 
Participants with complete data 
(N = 1,147)
Variable                 Mean                               SD
Age (years) 40.20 10.86
Patient’s education (years) 11.62  3.51
Duration since first prescribed antipsychotic 
medication (years)
13.60 10.45
n % Frequency
Sex 
Male 853 74.4
   Female 288 25.1
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Note. CATIE = Clinical Antipsychotic Trials of Intervention Effectiveness  
Hypothesis 1  
 A Pearson correlation was conducted to evaluate the relationship between 
negative psychiatric symptom scores and scores on cognitive-deficit domain measures. 
The results demonstrated significant negative correlations between negative symptoms of 
psychosis and all cognitive-deficit domains identified for this study: Attention/Vigilance, 
Processing Speed, Reasoning/Problem Solving, Memory, and overall Neurocognitive 
Composite score (see Table 3).   
 Specifically, the results indicated a significant negative correlation between 
negative symptoms of psychosis and Attention/Vigilance, r = -.202, p < .01 (see Table 3). 
This negative correlation suggests that participants with higher scores of negative 
symptoms had lower scores on measures of attention.  
Race 
    Unknown    2 0.5
White 706 61.6
Black 380 33.1
Asian  27   2.4
Employment status 
Unknown   7 0.6
Full time  81 7.1
Part time
102 8.9
      
    Unemployed
951 82.9
Participants with complete data 
(N = 1,147)
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 The results also indicated a significant negative correlation between negative 
symptoms of psychosis and Processing Speed, r = -.262, p < .01 (see Table 3). This 
negative correlation suggests that participants with greater negative symptoms of 
psychosis had lower scores on measures of speed of processing.  
 Similarly, a significant negative correlation was also identified in relation to 
negative symptoms of psychosis and Reasoning/Problem Solving, r = -.118, p < .01 (see 
Table 3). This negative correlation indicates that participants with greater negative 
symptoms scored lower on reasoning and problem-solving measures.  
 A significant negative correlation was also found between negative symptoms of 
psychosis and Memory, r = -.191, p < .01 (see Table 3). These results suggest that 
patients with greater negative psychotic symptoms scored lower on memory measures.  
 Finally, a significant negative correlation was identified between negative 
symptoms of psychosis and overall Neurocognitive Composite scores, which are an 
average of one’s cognitive abilities on the whole, r = -.260, p < .01 (see Table 3). This 
negative correlation suggests that individuals with greater negative symptoms of 
psychosis perform lower across all cognitive domains.  
Table 3 
Hypothesis 1: Correlation Matrix for Variables with Negative Symptoms of Psychosis 
Variable NEGSX ATT/V PSP R/PS MEM NCOMP
NEGSX --- -.202** -.262** -.118** -.191** -.260**
ATT/V ---  .576**  .388**  .514** .745**
PSP ---  .520**  .607** .838**
R/PS ---  .504** .718**
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Note. N = 1,147 .NCOMP = Neurocognitive Composite Score, NEGSX = Negative symptoms of 
psychosis, Positive and Negative Syndrome Scale (PANSS; Kay, Fiszbein, & Opler, 1987). ATT/V = 
Attention/Vigilance, Continuous Performance Test, Identical Pairs Versions (CPT-IP; Cornblatt et al., 
1988). PSP = Processing speed, The Wechsler Adult Intelligence Test-Revised (WAIS-R) Digit Symbol Test 
(Wechsler, 1955). R/PS = Reasoning and problem solving, The Wisconsin Card Sorting Test, 64-Card 
Computerized Version (WCST-64P; Kongs et al., 2000). MEM = Memory, The Hopkins Verbal Learning 
Test (HVLT; (Brandt & Benedict, 1991), The Computerized Test of Visuospatial Working Memory 
(Hershey et al., 1999). 
* p < .05. **p < .01. 
Hypothesis 2  
 A Pearson correlation was conducted to evaluate the relationship between positive 
psychiatric symptom scores and scores on cognitive-deficit domain measures. In 
particular, a Pearson correlation was conducted to determine relationships, if any, 
between positive symptoms of psychosis and cognitive-deficit domains identified for this 
study, including Attention/Vigilance, Processing Speed, Reasoning/Problem Solving, 
Memory, and overall Neurocognitive Composite. Of the cognitive-deficit domains, only 
Memory had a significant relationship with positive symptoms of psychosis. Specifically, 
the results indicated a significant negative correlation between positive symptoms of 
psychosis and Memory, r = -.067, p < .05 (see Table 4). This correlation suggests that 
participants with higher scores on positive symptom measures had lower scores on 
measures of memory.  
MEM --- .819**
NCOMP ---
Variable NEGSX ATT/V PSP R/PS MEM NCOMP
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 In contrast, the results indicated no significant relationships between positive 
symptoms of psychosis and Attention/Vigilance or Processing Speed, r = -.001, p = .965, 
and r = .021, p = .488, respectively (see Table 4).  
 Furthermore, no significant relationship was identified between positive 
symptoms of psychosis and Reasoning/Problem Solving or overall Neurocognitive 
Composite scores, r = -.010, p = .726, and r = -.026, p = 0.382, respectively (see Table 4).  
Table 4 
Hypothesis 2: Correlation Matrix for Variables with Positive Symptoms of Psychosis 
Note. N = 1,147. NCOMP = Neurocognitive Composite Score, POSSX = Positive symptoms of psychosis, 
Positive and Negative Syndrome Scale (PANSS; Kay, Fiszbein, & Opler, 1987). ATT/V = Attention/
Vigilance, Continuous Performance Test, Identical Pairs Versions (CPT-IP; (Cornblatt et al., 1988). PSP = 
Processing speed, The Wechsler Adult Intelligence Test-Revised (WAIS-R) Digit Symbol Test (Wechsler, 
1955). R/PS = Reasoning and problem solving, The Wisconsin Card Sorting Test, 64-Card Computerized 
Version (WCST-64P; Kongs et al., 2000). MEM = Memory, The Hopkins Verbal Learning Test (HVLT; 
Brandt & Benedict, 1991), The Computerized Test of Visuospatial Working Memory (Hershey et al., 1999). 
* p < .05. **p < .01. 
Hypothesis 3 
 A nonhierarchical K-mean cluster analysis was performed to identify homogenous 
groups based on standardized scores across all neurocognitive and symptom domains. 
Variable POSSX ATT/V PSP R/PS MEM NCOMP
POSSX --- -0.001 0.021 -0.010 -.067* -0.026
ATT/V ---     .576**      .
388**
    .514** .745**
PSP ---     .520**     .607** .838**
R/PS ---    .504** .718**
MEM --- .819**
NCOMP ---
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The clustering method used assumes a number of clusters (K) apriori. Each data point is 
subsequently combined with other data points with the closest Euclidean distance to the 
K cluster center. Cluster cohesion was optimal at the two-cluster level (i.e., K = 2), as the 
Cluster 1 and Cluster 3 solutions did not create cohesive clusters. Closeness was 
determined by identifying the centroids of each cluster. Centroids are artificial data points 
that represent the average of all data points in the cluster. Once the centroids were 
determined, Euclidean distance of each data point from its centroid was then calculated, 
producing successive iterations until the maximum number of iterations was achieved 
(Table 5). The maximum number of iterations performed was 10, and the iterations failed 
to converge. Nonetheless, each successive iterative yielded a smaller variance, indicating 
strong cohesion between each data point and its assigned cluster. The maximum absolute 
coordinate change for any center was .010, with the minimum distance between initial 
cluster centers being 10.889.  
Table 5 
Hypothesis 3: Iteration History of Change in Cluster Centers 
Iteration Change in Cluster Centers
Cluster 1 Cluster 2
1 4.856 4.158
2 .314 .201
3 .156 .105
4 .068 .046
5 .045 .031
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 The final cluster centers differed on the two variables of interest: cognitive 
domains and psychotic symptoms. That is, Cluster 1 was representative of participants 
who scored high on both positive and negative symptoms of psychosis and were more 
compromised across all cognitive domains as compared to Cluster 2. Conversely, Cluster 
2 was representative of participants who had a lower presence of both positive and 
negative symptoms and displayed better cognitive functioning overall. These differences 
are noted in Table 6.  
Table 6
Hypothesis 3: Final Cluster Centers from the K-Means Cluster Analysis (N = 1,147) 
Note. NEGSX = ATT/V = Attention/Vigilance, Continuous Performance Test, Identical Pairs Versions 
(CPT-IP; Cornblatt et al., 1988). PSP = Processing speed, The Wechsler Adult Intelligence Test-Revised 
(WAIS-R) Digit Symbol Test (Wechsler, 1955). R/PS = Reasoning and problem solving, The Wisconsin 
Card Sorting Test, 64-Card Computerized Version (WCST-64P; Kongs et al., 2000). MEM = Memory, The 
Hopkins Verbal Learning Test (HVLT; Brandt & Benedict, 1991) & The Computerized Test of Visuospatial 
Working Memory (Hershey et al., 1999). Negative symptoms of psychosis, POSSX = Positive symptoms of 
psychosis, Positive and Negative Syndrome Scale (PANSS; Kay, Fiszbein, & Opler, 1987). 
6 .045 .033
7 .037 .027
8 .029 .022
9 .017 .013
10 .015 .012
Variable Cluster 1 Cluster 2
ATT/V -.661 .525
PSP -.773 .608
R/PS -.614 .483
MEM -.764 .601
NEGSX  .368 -.289
POSSX  .094 -.074
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 A posthoc analysis was performed by way of an analysis of variance (ANOVA) 
between Cluster 1 and Cluster 2. The ANOVA supported the cluster findings, as 
evidenced by significant differences across all variables between clusters. The effect size, 
calculated using eta squared, was large for all four cognitive domains and small for 
positive and negative symptoms. Findings from the ANOVA are summarized in Table 7. 
Table 7. 
Hypothesis 3: Analysis of Variance (ANOVA) Between Cluster 1 and Cluster 2 
 A chi-square analysis using cross-tabulation was performed to determine whether 
the clusters differed on demographic variables. The differences between clusters based on 
Mean 
square
df Mean 
square
df F Sig. Eta 
squared
ATT/V 393.040 1 .657 1143 598.227 .000** 0.225
PSP 537.625 1 .531 1143 1013.409 .000** 0.372
R/PS 339.884 1 .704 1143 483.124 .000** 0.341
MEM 525.410 1 .541 1143 970.828 .000** 0.351
NEGS
X
121.766 1 .894 1143 136.151 .000** 0.098
POSS
X
  7.934 1 .994 1143 7.982 .005* 0.015
Note. N = 1,147.  ATT/V = Attention/Vigilance, Continuous Performance Test, Identical 
Pairs Versions (CPT-IP; Cornblatt et al., 1988). PSP = Processing speed, The Wechsler 
Adult Intelligence Test-Revised (WAIS-R) Digit Symbol Test (Wechsler, 1955). R/PS = 
Reasoning and problem solving, The Wisconsin Card Sorting Test, 64-Card Computerized 
Version (WCST-64P; (Kongs et al., 2000). MEM = Memory, The Hopkins Verbal Learning 
Test (HVLT; Brandt & Benedict, 1991) & The Computerized Test of Visuospatial Working 
Memory (Hershey et al., 1999). NEGSX = Negative symptoms of psychosis, POSSX = 
Positive symptoms of psychosis, Positive and Negative Syndrome Scale (PANSS; Kay, 
Fiszbein, & Opler, 1987). 
* p < .05. **p < .01.
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race were significant. That is, Cluster 2, which was determined to be less compromised 
overall, was comprised of significantly more White participants than Black participants 
as compared to Cluster 1, (Χ2(7) = 33.049, p < .001; see Table 8). Employment was also 
found to be significantly different between the two clusters. Specifically, participants in 
Cluster 2 were more likely to have a work history as compared to those in Cluster 1, 
(Χ2(4) = 16.940, p = .002; see Table 9). Gender was not significantly different between 
the two clusters.  
 Next, a multivariate analysis of variance (MANOVA) was performed to test 
differences between the clusters on two variables: (a) the number of years since first 
prescribed antipsychotic medication, and (b) number of years of education.  However, a 
Table 8. 
Chi-Square Analysis for Race
Value df Asymptotic significance 
Pearson chi-square 33.049a 7 .000
Likelihood ratio 35.009 7 .000
N of valid cases 1,145
Note. a Eight cells (50.0%) have expected count less than 5. The minimum expected count is .88.
Table 9. 
Chi-Square Analysis for Employment
Value df Asymptotic significance 
Pearson chi-square 16.940a 4 .002
Likelihood ratio 17.524 4 .002
N of valid cases 1,145
Note. Four cells (40.0%) have expected count less than 5. The minimum expected count is 1.76.
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significant Levene’s test, F = 20.25, p < .001, indicated a violation of the homogeneity of 
variance, prompting the use of a Welch’s t test. Findings from the Welch’s t test (see 
Table 10) indicate significant differences between the two clusters on these variables. 
That is, the participants in the more compromised group (Cluster 1) have fewer years of 
education, t(972.03) = -5.92, p < .001, and more years since first prescribed antipsychotic 
medication, t(924.80) = 7.53, p < .001, as compared to the less compromised group 
(Cluster 2).  
Table 10. 
Independent Samples Test Between Education Years and Years Prescribed 
Levene’s test for equality of 
variances
t-test for equality of 
means
F Sig. t df Sig.
Mean 
Differenc
e
Std. Error 
Differenc
e
Educatio
n years
Equal 
variances 
assumed
20.25 .000
-6.0
3
1132 .000 -1.25 .207
Equal 
variances 
not 
assumed
-5.9
2
972 .000 -1.25 .211
Yrs_pres Equal 
variances 
assumed
28.34 .000 7.72 1112 .000 4.75 .615
Equal 
variances 
not 
assumed
7.53 924 .000 4.75 .631
Note. Education years = Number of years of education. Yrs_pres = Number of years since 
first prescribed antipsychotic medication 
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Chapter 7: Discussion 
 The present study aimed to categorize subtypes of schizophrenia based on 
differences in two symptom types: cognitive deficits and positive and negative symptoms 
of psychosis. Test scores derived from neuropsychological and positive/negative 
psychotic-symptom measures were obtained via an archival dataset and analyzed with 
three hypotheses in mind. The first two hypotheses suggested distinct relationships 
between positive and negative symptoms of psychosis and domain-specific cognitive 
deficits. These hypotheses originated from the assumption that cognitive deficits in 
psychosis are specific to certain cognitive domains depending on the type and severity of 
the psychotic presentation (Gilbert et al., 2014). The assumption of domain-specific 
deficits contrasts with other schools of thought in which globalized cognitive deficits 
(i.e., deficits across all cognitive domains) are thought to be implicated in schizophrenia.  
 Specifically, the first hypothesis suggested negative symptoms of psychosis would 
be positively correlated with deficits in executive functioning and processing speed, 
meaning individuals who scored high on negative symptoms would have more severe 
deficits in complex problem solving and rapidity of processing tasks. Conversely, the 
results indicated that individuals who scored high on negative symptoms, scored lower 
across all cognitive domains: memory, attention, problem solving, and processing speed. 
Thus, the results were inconsistent with the domain-specific cognitive-deficit theory and 
instead supported the globalized-deficit approach.  
 Similarly, the second hypothesis posited that individuals who scored high on 
measures of positive symptoms would score lower on measures of memory and attention. 
IDENTIFYING SUBTYPES OF SCHIZOPHRENIA                                                       59
The results indicated a significant relationship between memory and positive symptoms 
only, suggesting that individuals with greater positive symptoms performed poorer on 
memory tasks as compared to other cognitive domains. Since attention deficits were not 
significantly related to positive symptoms, one can surmise that individuals with 
predominant positive symptoms have difficulty encoding and thus later recalling 
information, but do not necessarily have difficulty attending to the information in the first 
place.  
 On the whole, individuals with more severe negative symptoms than positive 
symptoms experience greater deficits across all cognitive domains, whereas individuals 
with more severe positive symptoms experience deficits that are specific to memory. One 
theory to explain this notion is that positive symptoms and negative symptoms of 
psychosis likely have distinct neurological substrates. Moreover, negative symptoms, 
such as apathy, flattened affect, social withdrawal, and avolition, are components that 
necessitate and underlie many cognitive processes (Erhart et al., 2006). Thus, without 
motivation, attention, and emotional interest, all types of cognitive processes are 
hindered.  
 Positive symptoms, however, require an overproduction of the perceptual system, 
whereby attention and problem solving are germane to hypervigilance, paranoia, and 
delusions. Recent studies have identified a relationship between working-memory deficits 
and delusions, with the idea being that working memory is required for coming to 
rational conclusions about everyday experiences (Freeman et al., 2013). Thus, a positive 
correlation between positive symptoms of psychosis and memory deficits is conceivable.  
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 The final hypothesis suggested that subtypes of schizophrenia could be gleaned 
from the application of a cluster analysis. The results obtained herein suggest the 
existence of two subtypes of schizophrenia. The first subtype, hereafter referred to as the 
Deficit subtype, was comprised of participants who scored lower across all cognitive 
domains and higher on scores of positive and negative symptoms of psychosis. 
Conversely, the second subtype, hereafter referred to as the Nondeficit subtype, was 
comprised of individuals who scored higher across all cognitive domains and lower on 
positive and negative symptoms. The delineation of these subtypes was clear. Thus, 
schizophrenia as a broad diagnostic category is actually comprised of two distinct 
phenomena, and possibly two distinct diagnoses entirely.  
 Moreover, the two subtypes identified in the present study differed significantly 
on the following variables of interest: race, employment, education, and history of 
antipsychotic medication. Specifically, the Deficit subtype was comprised of more Black 
participants than White, had fewer years of education, and had a longer duration since 
first prescribed antipsychotic medication. The Nondeficit subtype, conversely, was 
comprised of more White than Black participants, had a longer work history, had more 
education, and had fewer years since first prescribed antipsychotic medication. One 
potential explanation is that socioeconomic factors play a large role in onset and course 
of illness in schizophrenia. Specifically, education and work history may serve as 
protective factors against an earlier age at onset, as well as against symptom severity and 
associated cognitive deficits.  
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Implications 
 Individuals with schizophrenia vary considerably in onset, severity, course, and 
duration of their illness (Buchanan & Carpenter, 1994). The need for subtypes to reduce 
this variability has been well documented in the literature (Fenton & McGlashan, 1991). 
The implications for this study are trifold: (a) Identifying subtypes of schizophrenia may 
reduce the widespread heterogeneity inherent in the disorder, and thus perhaps improve 
diagnostic clarity; (b) Using a neurocognitively driven approach to conceptualizing the 
disorder can elucidate the etiology and pathophysiology of schizophrenia through 
identifying brain-behavior relationships, which may have further implications on risk 
management and prevention; and  (c) diagnostic clarity and specificity can foster accurate 
treatment targets, which could consequently improve treatment outcomes.  
 Subtypes based on attempts at symptomatic differentiation from previous editions 
of the Diagnostic and Statistical Manual of Mental Disorders were unsuccessful in 
clarifying the etiopathophysiology or heterogeneity in schizophrenia (Braff et al., 2013). 
Essentially, the tendency for symptom overlap and transient manifestations of symptoms 
detracted from their utility, meaning that symptoms were unreliable markers of subtypes 
(Tandon et al., 2013). Nonetheless, the need to identify homogenous groups within 
schizophrenia to inform treatment remains evident. The neurocognitive correlates of 
schizophrenia are stable and reliable indicators of the disorder (Bora, 2014). Thus, basing 
subtypes on neurocognitive, rather than symptomatic, data will likely yield lasting 
etiological subtypes. 
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  Furthermore, this type of phenotypic refinement has been applied successfully in 
other complex disorders, such as Parkinson’s disease (Dekker et al., 2003) and 
Alzheimer’s disease (Scott et al., 2003), both of which have demonstrated advances in 
diagnostic, conceptual, and treatment dimensions as a result (Geisler et al., 2015). The 
primary implication of identifying subtypes of schizophrenia based on differential 
neurocognitive profiles rests in its ability to explicate distinct etiologic mechanisms. 
Research suggests that the etiology and onset of schizophrenia can be caused by a 
multitude of factors and that differences at onset might  likely account for the 
heterogeneity in schizophrenia as a whole (Rajji, Ismail, & Mulsant, 2009). Research has 
further suggested that factors at onset, such as age, severity, and type of episode, may be 
linked to specific subtypes. For example, individuals with an earlier age at onset are more 
likely to have profound memory deficits and experience more positive symptoms than 
those who develop schizophrenia later on (Johnstone et al., 1989). Thus, identifying 
subtypes in this way may further an understanding of the relationship between the onset 
and course of schizophrenia, which may in turn inform prevention strategies and risk 
management (Zhang et al., 2015).  
 Finally, this study has implications on the course and type of treatment in 
schizophrenia. Reducing the heterogeneity aids in individualized treatment plans (Gilbert 
et al., 2014). Tailoring treatment to the individual is especially important in 
schizophrenia, given the extraordinary variability among patients. In addition to 
individualized treatment protocols, identifying neuropsychologically based subtypes may 
alter the focus of treatment from traditional to computerized approaches. Recently, 
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cognitive-based interventions akin to those used in cases of traumatic brain injury and 
neurological disorders, such as cognitive remediation now used in schizophrenia, have 
surged (Medalia & Saperstein, 2013). Identifying subtypes of schizophrenia based on 
differential neurocognitive profiles can inform cognitive-remediation regimens that target 
the cognitive deficits that are specific to that subtype. In turn, these individualized 
treatment plans will likely engender better treatment outcomes. Specifically, cognitive 
deficits in schizophrenia have been highly correlated with functional outcomes (Medalia 
& Saperstein, 2013). Thus, this treatment approach will likely have implications on 
patients’ quality of life, activities of daily living, and general social and occupational 
functioning.  
 The Deficit and Nondeficit subtype groups outlined in this study can assist in 
improving diagnostic accuracy. Specifically, individuals may be diagnosed based 
predominantly on their neurocognitive profiles. Neurocognitive profiles with globalized 
cognitive deficits would likely fit the Deficit subtype, whereas those scoring low only in 
memory would likely belong to the Nondeficit subtype. This categorization would then 
aid in the selection of appropriate treatment options. Those belonging to the Nondeficit 
subtype would likely benefit from cognitive remediation of memory, in hopes that 
improved memory will assist in the cognitive restructuring of delusions and thereby 
reduce positive symptoms, whereas the Deficit subtype would likely benefit from a 
globalized cognitive-remediation approach. Moreover, education and work history may 
serve as protective factors against symptom severity and associated cognitive deficits. 
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Therefore, prevention strategies could utilize this subtyping method for early intervention 
via the implementation of education and employment programs for at-risk individuals.  
Limitations 
 A potential limitation of this study is the exclusion of psychotic-spectrum 
disorders that are not schizophrenia. Some researchers conceptualize schizophrenia as a 
part of a continuum along the psychotic disorders spectrum and believe that its current 
classification is erroneous, limited, and flawed. Through excluding other psychotic-
spectrum disorders, one risks subscribing to the confines of a diagnostic category that 
might limit or impede a more thorough understanding of psychosis in general. Therefore, 
a possible limitation of this study is that the results are reflective of an already flawed 
diagnostic system.  
 Other potential limitations may stem from the archival dataset used in the current 
study. Namely, the aims of the parent study required a sampling of typical and atypical 
antipsychotics. It is widely acknowledged that typical, or first-generation, antipsychotics 
often impair cognitive functioning further in schizophrenia (Han et al., 2015). By not 
controlling for these variables, some of the neuropsychological performances across 
participants might have been unduly influenced by medication effects. Similarly, 
participants with incomplete data were deleted from the present study; therefore, whether 
the missing data was the result of random or systematic occurrence cannot be determined. 
Therefore, another limitation is possibly unaccounted-for differences between the sample 
and population that cannot be ascertained in the current analysis.  
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 Furthermore, the present study examined the associations between positive and 
negative symptoms of psychosis as they relate to cognitive deficits. Some researchers 
argue that this binary conceptualization is, in fact, a false dichotomy and that psychosis is 
actually composed of a variety of symptom domains (David & Appleby, 1992). Similarly, 
neurocognitive deficits included in this study were based on cognitive domains most 
commonly implicated in schizophrenia. The results must be interpreted with the 
limitation that other cognitive domains, such as social cognition, were not included. 
  Likewise, despite growing research in favor of a domain-specific deficit approach 
to cognition in schizophrenia, a body of literature favors the generalized-deficit theory. 
The generalized-deficit theory states that individuals with schizophrenia have cognitive 
deficits across all domains, such as memory and executive functioning, and that 
differential impairments do not exist (Dickinson et al., 2008). A major limitation of this 
study, then, is that it is based on the assumption that individuals with schizophrenia are 
differentially impaired across cognitive domains and that these differences are associated 
with specific symptom presentations as well. The present study failed to align with the 
domain-specific theory, but rather more so supported the globalized-deficit approach. 
Moreover, one should note that the correlations presented between cognitive deficits and 
psychotic symptoms are likely attenuated by the limited reliability of the measures. What 
has been presented herein are the raw correlations. 
 Likewise, this study is limited by not controlling for differences in premorbid 
adjustment and age of onset. Studies have consistently indicated that premorbid 
adjustment and age of onset can have a profound impact on the nature, course, and 
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severity of both cognitive deficits and symptom presentations in schizophrenia (Rund et 
al., 2004). The findings often indicate that earlier age of onset yields a poorer prognosis 
in regard to cognitive deficits and that better premorbid adjustment can predict better 
cognitive performances at later points in time (Fuller et al., 2002). Thus, not controlling 
for these variables suggests the results may be a reflection of differences that predate the 
disorder itself.  
Future Research 
 Future research should include all psychotic-spectrum disorders to determine 
whether greater clusters of subtypes are more representative of psychosis than are the 
predetermined diagnostic categories in the DSM-5. This delineation might help to fully 
restructure the current criteria from which diagnoses are made. Furthermore, future 
research should include a measure of social cognition, as it is another cognitive domain 
implicated in schizophrenia that was not examined in the present study. Social cognition 
is an emerging dimension of schizophrenia that is linked to functional outcomes (Fett, 
Viechtbauer, Penn, van Os, & Krabbendam, 2011). Therefore, identifying patterns of 
social cognition as they relate to other cognitive deficits and psychotic symptoms may 
elucidate another subtype that has yet to be explored, and one that may have implications 
on functional outcomes for individuals with schizophrenia. Additionally, future studies 
should work to control for variations that predate disease onset and to attempt to replicate 
the current findings.  
 Finally, future research should look to converge the literature on structural 
magnetic resonance imaging (MRI) in schizophrenia with the literature on subtypes. 
IDENTIFYING SUBTYPES OF SCHIZOPHRENIA                                                       67
Previous studies have attempted to demonstrate structural differences in the brain among 
previously established subtypes of schizophrenia (Gur et al., 1994; Turetsky et al., 1995; 
Sallet et al., 2003). Future research should look to validate the subtypes outlined in this 
study via structural MRI differentiation. Doing so may explicate the pathophysiology and 
etiology of schizophrenia, with subsequent implications on intervention strategies as well.  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